Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.16.2 (
PCP
)
3,761
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Addictive drugs, such as opioids, ethanol, cocaine, amphetamine, and phencyclidine (
PCP
), affect many functions of the nervous system and peripheral organs, resulting in severe health problems. G protein-activated inwardly rectifying K(+) (GIRK, Kir3) channels play an important role in regulating neuronal excitability through activation of various Gi/o protein-coupled receptors including opioid and CB(1) cannabinoid receptors. Furthermore, the channels are directly activated by ethanol and inhibited by cocaine at toxic levels, but not affected by methylphenidate, methamphetamine, and 3,4-methylenedioxymethamphetamine (MDMA) at toxic levels. The primary pharmacological action of
PCP
is blockade of N-methyl-D-aspartate (NMDA) receptor channels that are associated with its psychotomimetic effects.
PCP
also interacts with several receptors and channels at relatively high concentrations. However, the molecular mechanisms underlying the various effects of
PCP
remain to be clarified. Here, we investigated the effects of
PCP
on GIRK channels using the Xenopus oocyte expression system.
PCP
weakly but significantly inhibited GIRK channels at micromolar concentrations, but not Kir1.1 and
Kir2.1
channels. The
PCP
concentrations effective in inhibiting GIRK channels overlap clinically relevant brain concentrations in severe intoxication. The results suggest that partial inhibition of GIRK channels by
PCP
may contribute to some of the toxic effects after overdose.
...
PMID:Inhibition of g protein-activated inwardly rectifying k channels by phencyclidine. 2188 98